Gregory Eschenauer

2.2k total citations
39 papers, 1.0k citations indexed

About

Gregory Eschenauer is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Gregory Eschenauer has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 23 papers in Infectious Diseases and 9 papers in Pharmacology. Recurrent topics in Gregory Eschenauer's work include Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (14 papers) and Antibiotic Use and Resistance (7 papers). Gregory Eschenauer is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (14 papers) and Antibiotic Use and Resistance (7 papers). Gregory Eschenauer collaborates with scholars based in United States, Taiwan and Australia. Gregory Eschenauer's co-authors include Peggy L. Carver, Daryl D. DePestel, Simon W. Lam, Cornelius J. Clancy, Brian A. Potoski, Ryan K. Shields, Burgunda V. Sweet, M. Hong Nguyen, Twisha S Patel and Christine J. Kubin and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Gregory Eschenauer

36 papers receiving 1.0k citations

Peers

Gregory Eschenauer

EPIDE

AMB

PHARM

Rupali Jain United States

Michele Wible United States

Twisha S Patel United States

Lloyd Clarke United States

Anke Kohlenberg Germany

M.P. Molinari Italy

Sungmin Kiem South Korea

Frank Tverdek United States

Alessia Carnelutti Italy

Emily S Spivak United States

Rupali Jain United States

Gregory Eschenauer

419 ×0.7

EPIDE

412 ×0.8

335 ×1.5

144 ×0.7

AMB

322 ×1.8

PHARM

Citations per year, relative to Gregory Eschenauer Gregory Eschenauer (= 1×) peers Rupali Jain

Countries citing papers authored by Gregory Eschenauer

Since Specialization

Citations

This map shows the geographic impact of Gregory Eschenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Eschenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Eschenauer more than expected).

Fields of papers citing papers by Gregory Eschenauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Eschenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Eschenauer. The network helps show where Gregory Eschenauer may publish in the future.

Co-authorship network of co-authors of Gregory Eschenauer

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Eschenauer. A scholar is included among the top collaborators of Gregory Eschenauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Eschenauer. Gregory Eschenauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loo, Angela, et al.. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy. 79(8). 1877–1884.

Arora, Nonie S., Rebecca Hanson, Jerod Nagel, et al.. (2023). A novel 2-step process for the management of inpatient beta-lactam allergy labels. Annals of Allergy Asthma & Immunology. 132(4). 525–531.e1. 1 indexed citations

Eschenauer, Gregory. (2023). Antifungal Therapies for Aspergillus spp.: Present and Future. Seminars in Respiratory and Critical Care Medicine. 45(1). 61–68. 4 indexed citations

Pogue, Jason M., Adam S. Lauring, Tejal Gandhi, et al.. (2021). Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants. Open Forum Infectious Diseases. 8(7). ofab268–ofab268. 1 indexed citations

Mills, John, Christopher Zimmerman, Tejal Gandhi, et al.. (2020). Incorporating preauthorization into antimicrobial stewardship pharmacist workflow reduces Clostridioides difficile and gastrointestinal panel testing. Infection Control and Hospital Epidemiology. 41(10). 1136–1141. 9 indexed citations

Foolad, Farnaz, Angela Huang, Cynthia T. Nguyen, et al.. (2018). A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia. Journal of Antimicrobial Chemotherapy. 73(5). 1402–1407. 36 indexed citations

Foolad, Farnaz, Jerod Nagel, Gregory Eschenauer, Twisha S Patel, & Cynthia T. Nguyen. (2017). Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management. Journal of Antimicrobial Chemotherapy. 72(12). 3232–3244. 16 indexed citations

Nagel, Jerod, Twisha S Patel, Tejal Gandhi, et al.. (2016). Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection. American Journal of Infection Control. 44(12). 1539–1543. 12 indexed citations

Patel, Twisha S, Gregory Eschenauer, Linda J. Stuckey, & Peggy L. Carver. (2016). Antifungal Prophylaxis in Lung Transplant Recipients. Transplantation. 100(9). 1815–1826. 29 indexed citations

10.

Eschenauer, Gregory, Simon W. Lam, & Bruce A. Mueller. (2016). Dose Timing of Aminoglycosides in Hemodialysis Patients: A Pharmacology View. Seminars in Dialysis. 29(3). 204–213. 9 indexed citations

11.

Nguyen, Cynthia T., et al.. (2015). Impact of an antimicrobial stewardship-led intervention forStaphylococcus aureusbacteraemia: a quasi-experimental study. Journal of Antimicrobial Chemotherapy. 70(12). dkv256–dkv256. 36 indexed citations

12.

Eschenauer, Gregory, et al.. (2015). Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia. Annals of Pharmacotherapy. 49(9). 1068–1074. 20 indexed citations

13.

Eschenauer, Gregory, M. Hong Nguyen, Shmuel Shoham, et al.. (2014). Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates. Antimicrobial Agents and Chemotherapy. 58(4). 1897–1906. 54 indexed citations

14.

Eschenauer, Gregory, E.J. Kwak, Abhinav Humar, et al.. (2014). Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients. American Journal of Transplantation. 15(1). 180–189. 56 indexed citations

15.

Eschenauer, Gregory & Peggy L. Carver. (2013). The Evolving Role of Antifungal Susceptibility Testing. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(5). 465–475. 21 indexed citations

16.

Eschenauer, Gregory, Peggy L. Carver, Shu‐Wen Lin, et al.. (2012). Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 68(4). 922–926. 39 indexed citations

17.

Shields, Ryan K., Cornelius J. Clancy, E.J. Kwak, et al.. (2012). Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients. PLoS ONE. 7(12). e52349–e52349. 105 indexed citations

18.

Eschenauer, Gregory, et al.. (2010). Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagnostic Microbiology and Infectious Disease. 67(2). 180–184. 89 indexed citations

19.

Lam, Simon W., Gregory Eschenauer, & Peggy L. Carver. (2009). Evolving role of early antifungals in the adult intensive care unit. Critical Care Medicine. 37(5). 1580–1593. 19 indexed citations

20.

Eschenauer, Gregory, Simon W. Lam, & Peggy L. Carver. (2009). Antifungal prophylaxis in liver transplant recipients. Liver Transplantation. 15(8). 842–858. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact